be a major killer disease worldwide. Currently a third of world population is infected and
multiple-drug-resistant (mdr) TB registers maximum mortality by a single pathogen.
Nanomedicine provides enormous opportunity for developing novel drugs. We have recently
demonstrated surface-modified-lipophilic-nanosilica as drug to combat malaria and 100%
lethal virus, BmNPV. Nanosilver possesses inherent antibacterial properties, but toxicity is a …